Trial for this rare genetic disease to be conducted by NIH/NIAID in partnership with Corvus ITK inhibition intended to address dysregulation of T cells that causes ALPS and has been shown to be ...
Corvus Pharmaceuticals (CRVS) announced that the National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes ...
New research, led by Johns Hopkins Children's Center investigators and sponsored by the National Institutes of Health's (NIH) ...
Vaccines. Fluoride. Autism. Communications involving these and 20 other “controversial, high profile, or sensitive” topics ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how to increase uptake.
A Democratic member of Congress has emerged as a vocal defender of the status quo at the National Institutes of ...
In a new study, omalizumab, an injectable drug for food allergies, performed better than oral immunotherapy. A subsequent ...
The Trump administration’s orders have created more turmoil and damage at the National Institutes of Health than was ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...
2d
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback